Profile avatar
ivdp-hamburg.bsky.social
The Institute for Health Services Research in Dermatology and Nursing (IVDP) at the University Medical Center Hamburg-Eppendorf (UKE) encompasses research in dermatology, health economics, patient outcomes, nursing and midwifery and provides clinical care.
12 posts 10 followers 8 following
Regular Contributor

๐Ÿ‘‰๐Ÿ’กNew study links rising temperatures with increased heat-related #health issues in Germany. An analysis of health insurance data (2012-2021) shows Heat-related diagnosis spike in hotter months, highlighting urgent need for adaptation measures. ๐Ÿ“Œ #Climate #Heat ๐Ÿ‘‰ pubmed.ncbi.nlm.nih.gov/39446174/

๐Ÿ“๐Ÿ‘‰Measuring the #patient perspective in Long COVID! ๐Ÿ‘Many thanks to the Institute of Social Medicine and Health Systems Research in #Magdeburg, for inviting us to participate in this project! #longcovid #Covid #SARS-CoV-2 #Research @blomechristine.bsky.social ๐Ÿ‘‰ pubmed.ncbi.nlm.nih.gov/39806627/

๐Ÿ“Œ๐Ÿ“A study (2019-2021) with patients diagnosed with atopic dermatitis and undergoing GP treatment reveals that many patients experience poor outcomes. This could be due to both the rare use of modern therapies and the lack of participation in training programmes. ๐Ÿ‘‰ pubmed.ncbi.nlm.nih.gov/39226528/

๐Ÿ‘‰Lime-induced phytophotodermatitis, triggered by lime juice and sun exposure, presents with #erythema, #pruritis, and #bullae. In our case report, despite treatment, residual hyperpigmentation persisted, emphasizing the importance of recognizing sensitizing agents. pubmed.ncbi.nlm.nih.gov/39673137/

๐Ÿ‘‰ Children with #psoriasis have different needs and less options for medical therapies than adults. Close #collaboration with pediatricians and other specialties for systemic therapies are crucial for a well-managed #health care and compliance. pubmed.ncbi.nlm.nih.gov/39518448/ #PediatricPsoriasis

๐Ÿ‘๐Ÿ“ŠProf. Dr. Kristian Reich has earned the title of Highly Cited Researcher by #Clarivate_Analytics, ranking him among the top 1% of his field from 2013 to 2023. His influential research on inflammatory #skin diseases and emerging treatment strategies is driving innovation in #dermatological #care.๐Ÿ’ช

Preferences of patients with #malignant_melanoma to accept adjuvant therapy are based on treatment efficacy, side effects, and quality of life. Personalised approaches are essential for shared #decision-making. ๐Ÿ‘‡๐Ÿฝ๐Ÿ“„ pubmed.ncbi.nlm.nih.gov/39627632/

๐Ÿ”Wissenschaftliche:r Angestellte:r Junior (all genders) โ€“ Schwerpunkt "Statistik und Methodik" am UKE gesucht! ๐Ÿ” Werden Sie Teil unseres Teams! ๐Ÿ‘‰ Bewerben Sie sich bis 27.01.2025! ๐Ÿ‘‰ Details: uke.jobs/3961.

๐Ÿ‘‰ #New: We developed and validated the Patient Benefit Index (PBI) for #Epilepsy - a novel tool measuring patientsโ€™ need, treatment benefits and challenges in epilepsy #care. ๐Ÿ‘‰๐Ÿป๐Ÿ“ pubmed.ncbi.nlm.nih.gov/39612628/

๐Ÿ‘‰๐ŸผManaging moderate-to-severe #psoriasis in women planning #pregnancy is challenging. Our study shows that TNF-alpha blockers are more often chosen following guidelines for treatment. Family planning needs communication between patient and doctor for decision-making. pubmed.ncbi.nlm.nih.gov/39555230/

๐Ÿ‘‰๐Ÿป๐Ÿ“ŠOur large-scale data on late-onset #acne (acne tarda) in #Germany shows a relevant prevalence after adolescence, in particular in #women, resulting in about 950,000 involved. Specialised knowledge and health care for acne tarda and its comorbidities is needed๐Ÿ“ pubmed.ncbi.nlm.nih.gov/39422854/

๐Ÿ“People with visible skin conditions like #dermatitis, #psoriasis, #vitiligo, and #alopecia often face social and self-stigma. A new review explores factors behind this burden and highlights targets for psychosocial interventions. #HealthAwareness ๐Ÿ“„๐Ÿ‘‡๐Ÿป pubmed.ncbi.nlm.nih.gov/39247975/